Cell rounding in cultured human astrocytes and vascular endothelial cells upon inhibition of CK2 is mediated by actomyosin cytoskeleton alterations

Journal of Cellular Biochemistry

Volumn 113, Issue 9, 2012, Pages 2948-2956

  Kramerov, A A ^a   Ahmed, K ^b   Ljubimov, A V ^a,c  

^a Regenerative Medicine Institute   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

actin stress fibers; cell shape; cytoskeleton; myosin light chain; Protein kinase CK2; TBB, TBCA

Indexed keywords

CASEIN KINASE II; MYOSIN ADENOSINE TRIPHOSPHATASE; MYOSIN LIGHT CHAIN; RHO KINASE;

ACTIN MYOSIN INTERACTION; ANIMAL CELL; ARTICLE; ASTROCYTE; CELL CULTURE; CELL MOTILITY; CELL SHAPE; CONTROLLED STUDY; CYTOSKELETON; ENDOTHELIUM CELL; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MUSCLE CONTRACTILITY; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; RETINA NEOVASCULARIZATION;

ACTOMYOSIN; ANIMALS; ASTROCYTES; CASEIN KINASE II; CATTLE; CELL SHAPE; CINNAMATES; CYTOSKELETON; ENDOTHELIAL CELLS; HUMANS; MYOSIN LIGHT CHAINS; PHOSPHORYLATION; RATS; TRIAZOLES;

EID: 84863649137     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24171     Document Type: Article

References (42)

1. Abe K, Misawa M,. 2003. Astrocyte stellation induced by Rho kinase inhibitors in culture. Brain Res Dev Brain Res 143: 99-104.
2. Baorto DM, Mellado W, Shelanski ML,. 1992. Astrocyte process growth induction by actin breakdown. J Cell Biol 117: 357-367.
3. Canton DA, Litchfield DW,. 2006. The shape of things to come: An emerging role for protein kinase CK2 in the regulation of cell morphology and the cytoskeleton. Cell Signal 18: 267-275.
4. Carneiro AC, Fragel-Madeira L, Silva-Neto MA, Linden R,. 2008. A role for CK2 upon interkinetic nuclear migration in the cell cycle of retinal progenitor cells. Dev Neurobiol 68: 620-631.
5. Cory GO, Cramer R, Blanchoin L, Ridley AJ,. 2003. Phosphorylation of the WASP-VCA domain increases its affinity for the Arp2/3 complex and enhances actin polymerization by WASP. Mol Cell 11: 1229-1239.
6. Di Maira G, Salvi M, Arrigoni G, Marin O, Sarno S, Brustolon F, Pinna LA, Ruzzene M,. 2005. Protein kinase CK2 phosphorylates and upregulates Akt/PKB. Cell Death Differ 12: 668-677.
7. Dong JM, Leung T, Manser E, Lim L,. 2002. Cdc42 antagonizes inductive action of cAMP on cell shape, via effects of the myotonic dystrophy kinase-related Cdc42-binding kinase (MRCK) on myosin light chain phosphorylation. Eur J Cell Biol 81: 231-242.
8. Faust M, Schuster N, Montenarh M,. 1999. Specific binding of protein kinase CK2 catalytic subunits to tubulin. FEBS Lett 462: 51-56.
9. Ghosh S, Dorsey FC, Cox JV,. 2002. CK2 constitutively associates with and phosphorylates chicken erythroid ankyrin and regulates its ability to bind to spectrin. J Cell Sci 115: 4107-4115.
10. Götz C, Bachmann C, Montenarh M,. 2007. Inhibition of protein kinase CK2 leads to a modulation of androgen receptor dependent transcription in prostate cancer cells. Prostate 67: 125-134.
11. Goueli SA, Davis AT, Arfman E, Vessella R, Ahmed K,. 1990. Monoclonal antibodies against nuclear casein kinase NII (PK-N2). Hybridoma 9: 609-618.
12. Guerra B,. 2006. Protein kinase CK2 subunits are positive regulators of AKT kinase. Int J Oncol 28: 685-693.
13. Guerra B, Issinger OG,. 1999. Protein kinase CK2 and its role in cellular proliferation, development and pathology. Electrophoresis 20: 391-408.
14. Hall A,. 2005. Rho GTPases and the control of cell behaviour. Biochem Soc Trans 33: 891-895.
15. Höltje M, Hoffmann A, Hofmann F, Mucke C, Grosse G, Van Rooijen N, Kettenmann H, Just I, Ahnert-Hilger G,. 2005. Role of Rho GTPase in astrocyte morphology and migratory response during in vitro wound healing. J Neurochem 95: 1237-1248.
16. Kramerov AA, Saghizadeh M, Pan H, Kabosova A, Montenarh M, Ahmed K, Penn JS, Chan CK, Hinton DR, Grant MB, Ljubimov AV,. 2006. Expression of protein kinase CK2 in astroglial cells of normal and neovascularized retina. Am J Pathol 168: 1722-1736.
17. Kramerov AA, Saghizadeh M, Caballero S, Shaw LC, Li Calzi S, Bretner M, Montenarh M, Pinna LA, Grant MB, Ljubimov AV,. 2008. Inhibition of protein kinase CK2 suppresses angiogenesis and hematopoietic stem cell recruitment to retinal neovascularization sites. Mol Cell Biochem 316: 177-186.
18. Kramerov AA, Golub AG, Bdzhola VG, Yarmoluk SM, Ahmed K, Bretner M, Ljubimov AV,. 2011. Treatment of cultured human astrocytes and vascular endothelial cells with protein kinase CK2 inhibitors induces early changes in cell shape and cytoskeleton. Mol Cell Biochem 349: 125-137.
19. Kranenburg O, Moolenaar WH,. 2001. Ras-MAP kinase signaling by lysophosphatidic acid and other G protein-coupled receptor agonists. Oncogene 20: 1540-1546.
20. Li Calzi S, Neu MB, Shaw LC, Grant MB,. 2010. Endothelial progenitor dysfunction in the pathogenesis of diabetic retinopathy: Treatment concept to correct diabetes-associated deficits. EPMA J 1: 88-100.
21. Lim AC, Hou Z, Goh CP, Qi RZ,. 2004. Direct regulation of microtubule dynamics by protein kinase CK2. J Biol Chem 279: 4433-4439.
22. Ljubimov AV, Caballero S, Aoki AM, Pinna LA, Grant MB, Castellon R,. 2004. Involvement of protein kinase CK2 in angiogenesis and retinal neovascularization. Invest Ophthalmol Vis Sci 45: 4583-4591.
23. Mammoto A, Ingber DE,. 2009. Cytoskeletal control of growth and cell fate switching. Curr Opin Cell Biol 21: 864-870.
24. Meggio F, Pinna LA,. 2003. One-thousand-and-one substrates of protein kinase CK2? FASEB J 17: 349-368.
25. Miyata S, Furuya K, Nakai S, Bun H, Kiyohara T,. 1999. Morphological plasticity and rearrangement of cytoskeletons in pituicytes cultured from adult rat neurohypophysis. Neurosci Res 33: 299-306.
26. Padmanabhan J, Shelanski ML,. 1998. Process formation in astrocytes: Modulation of cytoskeletal proteins. Neurochem Res 23: 377-384.
27. Pagano MA, Poletto G, Di Maira G, Cozza G, Ruzzene M, Sarno S, Bain J, Elliott M, Moro S, Zagotto G, Meggio F, Pinna LA,. 2007. Tetrabromocinnamic acid (TBCA) and related compounds represent a new class of specific protein kinase CK2 inhibitors. Chembiochem 8: 129-139.
28. Perez V, Bouschet T, Fernandez C, Bockaert J, Journot L,. 2005. Dynamic reorganization of the astrocyte actin cytoskeleton elicited by cAMP and PACAP: A role for phosphatidylInositol 3-kinase inhibition. Eur J Neurosci 21: 26-32.
29. Ponce DP, Maturana JL, Cabello P, Yefi R, Niechi I, Silva E, Armisen R, Galindo M, Antonelli M, Tapia JC,. 2011. Phosphorylation of AKT/PKB by CK2 is necessary for the AKT-dependent up-regulation of β-catenin transcriptional activity. J Cell Physiol 226: 1953-1959.
30. Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, Parsons JT, Horwitz AR,. 2003. Cell migration: Integrating signals from front to back. Science 302: 1704-1709.
31. Ritt DA, Zhou M, Conrads TP, Veenstra TD, Copeland TD, Morrison DK,. 2007. CK2 is a component of the KSR1 scaffold complex that contributes to Raf kinase activation. Curr Biol 17: 179-184.
32. Rosso L, Peteri-Brunbäck B, Vouret-Craviari V, Deroanne C, Troadec JD, Thirion S, Van Obberghen-Schilling E, Mienville JM,. 2002. RhoA inhibition is a key step in pituicyte stellation induced by A(1)-type adenosine receptor activation. Glia 38: 351-362.
33. Rosso L, Pierson PM, Golfier C, Peteri-Brunbäck B, Deroanne C, Van Obberghen-Schilling E, Mienville JM,. 2007. Pituicyte stellation is prevented by RhoA-or Cdc42-dependent actin polymerization. Cell Mol Neurobiol 27: 791-804.
34. Schneider CC, Götz C, Hessenauer A, Günther J, Kartarius S, Montenarh M,. 2011. Down-regulation of CK2 activity results in a decrease in the level of cdc25C phosphatase in different prostate cancer cell lines. Mol Cell Biochem 356: 177-184.
35. Smolock EM, Wang T, Nolt JK, Moreland RS,. 2007. siRNA knock down of casein kinase 2 increases force and cross-bridge cycling rates in vascular smooth muscle. Am J Physiol Cell Physiol 292: C876-C885.
36. Tan I, Leung T,. 2009. Myosin light chain kinases: Division of work in cell migration. Cell Adh Migr 3: 256-258.
37. Tawfic S, Yu S, Wang H, Faust R, Davis A, Ahmed K,. 2001. Protein kinase CK2 signal in neoplasia. Histol Histopathol 16: 573-582.
38. Totsukawa G, Wu Y, Sasaki Y, Hartshorne DJ, Yamakita Y, Yamashiro S, Matsumura F,. 2004. Distinct roles of MLCK and ROCK in the regulation of membrane protrusions and focal adhesion dynamics during cell migration of fibroblasts. J Cell Biol 164: 427-439.
39. Wang D, Jang DJ,. 2009. Protein kinase CK2 regulates cytoskeletal reorganization during ionizing radiation-induced senescence of human mesenchymal stem cells. Cancer Res 69: 8200-8207.
40. Zhang Y, Stone J,. 1997. Role of astrocytes in the control of developing retinal vessels. Invest Ophthalmol Vis Sci 38: 1653-1666.
41. Zhang Y, Porat RM, Alon T, Keshet E, Stone J,. 1999. Tissue oxygen levels control astrocyte movement and differentiation in developing retina. Brain Res Dev Brain Res 118: 135-145.
42. Zhang X, Li C, Gao H, Nabeka H, Shimokawa T, Wakisaka H, Matsuda S, Kobayashi N,. 2011. Rho kinase inhibitors stimulate the migration of human cultured osteoblastic cells by regulating actomyosin activity. Cell Mol Biol Lett 16: 279-295.